Addus HomeCare Co. (NASDAQ:ADUS) Receives $131.63 Average Price Target from Brokerages

Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine analysts that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $131.63.

ADUS has been the topic of several research reports. Royal Bank of Canada lowered their target price on Addus HomeCare from $141.00 to $136.00 and set an "outperform" rating on the stock in a report on Wednesday, November 6th. Macquarie reaffirmed an "outperform" rating and set a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. TD Cowen increased their target price on Addus HomeCare from $128.00 to $137.00 and gave the stock a "buy" rating in a research report on Thursday, August 8th. Oppenheimer increased their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a research report on Monday, September 23rd. Finally, Stephens increased their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th.

Addus HomeCare Trading Down 1.6 %

Shares of Addus HomeCare stock traded down $2.01 during trading hours on Tuesday, hitting $125.94. 22,782 shares of the company were exchanged, compared to its average volume of 131,604. Addus HomeCare has a 1 year low of $81.67 and a 1 year high of $136.12. The business has a 50-day moving average of $129.50 and a 200-day moving average of $121.83. The stock has a market capitalization of $2.28 billion, a price-to-earnings ratio of 29.28, a P/E/G ratio of 2.23 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. During the same quarter in the prior year, the company posted $1.03 earnings per share. Addus HomeCare's quarterly revenue was up 7.1% on a year-over-year basis. As a group, research analysts anticipate that Addus HomeCare will post 4.58 earnings per share for the current fiscal year.

Insider Transactions at Addus HomeCare

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm's stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares of the company's stock, valued at approximately $429,165. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock worth $3,050,082 in the last three months. 4.60% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds have recently bought and sold shares of the business. Texas Permanent School Fund Corp grew its position in shares of Addus HomeCare by 0.6% in the 2nd quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company's stock worth $1,636,000 after acquiring an additional 82 shares in the last quarter. Arizona State Retirement System grew its position in shares of Addus HomeCare by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company's stock worth $527,000 after acquiring an additional 87 shares in the last quarter. UMB Bank n.a. grew its position in shares of Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company's stock worth $26,000 after acquiring an additional 88 shares in the last quarter. Inspire Investing LLC grew its position in shares of Addus HomeCare by 3.3% in the 3rd quarter. Inspire Investing LLC now owns 3,111 shares of the company's stock worth $414,000 after acquiring an additional 100 shares in the last quarter. Finally, New York State Teachers Retirement System grew its position in shares of Addus HomeCare by 1.2% in the 3rd quarter. New York State Teachers Retirement System now owns 8,510 shares of the company's stock worth $1,132,000 after acquiring an additional 100 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.